Isolated pulmonary langerhans cell histocytosis in a child: A rare case report

Dang Mai Lien, Le Thi Hong Hanh, Le Thanh Chuong, Nguyen Hoang Nam, Hoang Ngoc Thach, Phan Tuan Hung

Main Article Content

Abstract

Pulmonary Langerhans Cell Histiocytosis (pLCH) is a rare condition in children and belongs to the group of histiocytic disorders characterized by clonal proliferation of Langerhans cells. Diagnosis is often challenging because clinical manifestations and radiological findings are nonspecific and may mimic prolonged pneumonia or infectious interstitial lung disease. We report a case of a 34-month-old male child admitted with a three-month history of persistent cough and progressive respiratory failure, who showed no clinical improvement despite prolonged broad-spectrum antibiotic therapy. Chest imaging revealed diffuse interstitial lung involvement. Lung biopsy combined with molecular analysis identified a BRAF V600 mutation, leading to a definitive diagnosis of pulmonary Langerhans cell histiocytosis. Targeted therapy in combination with vinblastine resulted in marked clinical improvement, allowing discontinuation of oxygen therapy. This case highlights the importance of considering non-infectious causes in children with progressive interstitial lung disease and emphasizes the role of lung biopsy and genetic testing in establishing an accurate diagnosis to guide appropriate treatment.

Article Details

References

1. Lương HV, Trung NN. Bệnh phổi mô bào X hiếm gặp (Pulmonary Langerhans’ Cell Histiocytosis): Nhân 3 trường hợp khám và điều trị tại Bệnh viện Phổi Trung ương. Tạp chí Nghiên cứu Y học. 2025; 186(1): 324-332. doi:10.52852/tcncyh.v186i1.2904.
2. Allen CE, Merad M, McClain KL. Langerhans-Cell Histiocytosis. N Engl J Med. 2018; 379(9): 856-868.
3. Roden AC, Yi ES. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists’ Perspective. Arch Pathol Lab Med. 2016; 140(3): 230-240.
4. Haupt R, et al. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment. Pediatr Blood Cancer. 2013; 60(2): 175-184.
5. Coşkun Ç, Kutluk T, Yalçın B, et al. Pulmonary involvement in children with Langerhans cell histiocytosis. Turk J Pediatr. 2024; 66(3): 323-331.
6. Maller V, Abrahamyan D, Weerakkody Y, et al. Pulmonary Langerhans cell histiocytosis. Radiopaedia.org. Published online 2024. Updated 2025. Accessed January 13, 2026.
7. Barclay M, Devaney R, Bhatt JM. Paediatric pulmonary Langerhans cell histiocytosis. Breathe (Sheff). 2020; 16(200003).
8. Bhatia P, Singh M, Sharma M, et al. BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival. Blood Cells Mol Dis. 2020; 82: 102356.